235 related articles for article (PubMed ID: 27772724)
1. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
Zhang H; Gao XD
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):935-946. PubMed ID: 27772724
[TBL] [Abstract][Full Text] [Related]
2. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
Hanagata N
Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
4. Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides.
Zhang H; Yan T; Xu S; Feng S; Huang D; Fujita M; Gao XD
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():144-151. PubMed ID: 28183591
[TBL] [Abstract][Full Text] [Related]
5. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
Bjersing JL; Eriksson K; Tarkowski A; Collins LV
Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the Nuclease Resistance and Immunostimulatory Activity of CpG Oligodeoxynucleotides by Conjugation to Sugar-Immobilized Gold Nanoparticles.
Murata K; Harayama K; Shimoda M; Niimura M; Wakao M; Suda Y; Moroishi T; Shinchi H
Bioconjug Chem; 2024 Jun; 35(6):804-815. PubMed ID: 38718344
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
8. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
Front Immunol; 2018; 9():783. PubMed ID: 29720976
[TBL] [Abstract][Full Text] [Related]
9. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
[TBL] [Abstract][Full Text] [Related]
10. Self-assembly of poly-adenine-tailed CpG oligonucleotide-gold nanoparticle nanoconjugates with immunostimulatory activity.
Chen N; Wei M; Sun Y; Li F; Pei H; Li X; Su S; He Y; Wang L; Shi J; Fan C; Huang Q
Small; 2014 Jan; 10(2):368-75. PubMed ID: 23963797
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
[TBL] [Abstract][Full Text] [Related]
12. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
Vollmer J; Janosch A; Laucht M; Ballas ZK; Schetter C; Krieg AM
Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):165-75. PubMed ID: 12162699
[TBL] [Abstract][Full Text] [Related]
13. Safety of CpG oligodeoxynucleotides in veterinary species.
Ioannou XP; Griebel P; Mena A; Gomis SM; Godson DL; Mutwiri G; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
Antisense Nucleic Acid Drug Dev; 2003; 13(3):157-67. PubMed ID: 12954116
[TBL] [Abstract][Full Text] [Related]
14. Tuning CpG motif position in nanostructured DNA for efficient immune stimulation.
Tan M; Makiguchi N; Kusamori K; Itakura S; Takahashi Y; Takakura Y; Nishikawa M
Biotechnol J; 2024 Apr; 19(4):e2300308. PubMed ID: 38651249
[TBL] [Abstract][Full Text] [Related]
15. G-quadruplex-based CpG oligodeoxynucleotide/DOTAP complex strongly stimulates immunity in CpG motif-specific and loop-length-dependent manners.
Tu ATT; Hoshi K; Shobo M; Yamazaki T
Nanomedicine; 2022 Feb; 40():102508. PubMed ID: 34906721
[TBL] [Abstract][Full Text] [Related]
16. CpG ODN mimicking CpG rich region of myxosporean Myxobolus supamattayai stimulates innate immunity in Asian sea bass (Lates calcarifer) and defense against Streptococcus iniae.
U-Taynapun K; Chirapongsatonkul N; Itami T; Tantikitti C
Fish Shellfish Immunol; 2016 Nov; 58():116-124. PubMed ID: 27629917
[TBL] [Abstract][Full Text] [Related]
17. BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy.
Zhang H; Cheng T; Lai L; Deng S; Yu R; Qiu L; Zhou J; Lu G; Zhi C; Chen J
Nanoscale; 2018 Aug; 10(30):14516-14524. PubMed ID: 30024003
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides.
Zhang H; Chen W; Gong K; Chen J
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289
[TBL] [Abstract][Full Text] [Related]
19. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N
Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy.
Wilson KD; de Jong SD; Tam YK
Adv Drug Deliv Rev; 2009 Mar; 61(3):233-42. PubMed ID: 19232375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
